BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1452 related articles for article (PubMed ID: 19623515)

  • 21. The role of total thyroidectomy in the management of differentiated thyroid cancer.
    Stephenson BM; Wheeler MH; Clark OH
    Curr Opin Gen Surg; 1994; ():53-9. PubMed ID: 7584009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Poorly differentiated thyroid follicular carcinoma - a clinical analysis of 30 cases].
    Liu WS; Qi YF; Tang PZ
    Ai Zheng; 2004 Sep; 23(9):1081-4. PubMed ID: 15363207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer.
    Grünwald F; Menzel C; Fimmers R; Zamora PO; Biersack HJ
    J Nucl Med; 1996 Dec; 37(12):1962-4. PubMed ID: 8970514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO; Tari P; Tokmak E; Aras G
    Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.
    Schlumberger M; Challeton C; De Vathaire F; Travagli JP; Gardet P; Lumbroso JD; Francese C; Fontaine F; Ricard M; Parmentier C
    J Nucl Med; 1996 Apr; 37(4):598-605. PubMed ID: 8691248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Long-term course in differentiated thyroid gland carcinoma].
    Rösler H; Birrer A; Lüscher D; Kinser J
    Schweiz Med Wochenschr; 1992 Nov; 122(48):1843-57. PubMed ID: 1462145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
    Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
    J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extrathyroidal extension in well-differentiated thyroid cancer: macroscopic vs microscopic as a predictor of outcome.
    Hu A; Clark J; Payne RJ; Eski S; Walfish PG; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2007 Jul; 133(7):644-9. PubMed ID: 17638775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience.
    Terezakis SA; Lee KS; Ghossein RA; Rivera M; Tuttle RM; Wolden SL; Zelefsky MJ; Wong RJ; Patel SG; Pfister DG; Shaha AR; Lee NY
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):795-801. PubMed ID: 18676097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of external beam radiotherapy in the treatment of papillary thyroid cancer.
    Lee N; Tuttle M
    Endocr Relat Cancer; 2006 Dec; 13(4):971-7. PubMed ID: 17158749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective surgery and adjuvant therapy based on risk classifications of well-differentiated thyroid cancer.
    Cross S; Wei JP; Kim S; Brams DM
    J Surg Oncol; 2006 Dec; 94(8):678-82. PubMed ID: 17131414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group.
    La Quaglia MP; Black T; Holcomb GW; Sklar C; Azizkhan RG; Haase GM; Newman KD
    J Pediatr Surg; 2000 Jun; 35(6):955-9; discussion 960. PubMed ID: 10873043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
    Vassilopoulou-Sellin R; Schultz PN; Haynie TP
    Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postsurgical management of differentiated thyroid carcinoma.
    Mazzaferri EL; Robyn J
    Otolaryngol Clin North Am; 1996 Aug; 29(4):637-62. PubMed ID: 8844735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiated thyroid cancer in a Swedish county--long-term results and quality of life.
    Malterling RR; Andersson RE; Falkmer S; Falkmer U; Niléhn E; Järhult J
    Acta Oncol; 2010 May; 49(4):454-9. PubMed ID: 20092427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of locally aggressive well-differentiated thyroid cancer.
    Martins AS; Melo GM; Valério JB; Langner E; Lage HT; Tincani AJ
    Int Surg; 2001; 86(4):213-9. PubMed ID: 12056464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0.
    Lin JD; Lin KJ; Chao TC; Hseuh C; Tsang NM
    Radiother Oncol; 2008 Oct; 89(1):97-104. PubMed ID: 18534700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of the efficacy of iodine-131 for thyroid ablation.
    Comtois R; Thériault C; Del Vecchio P
    J Nucl Med; 1993 Nov; 34(11):1927-30. PubMed ID: 8229236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
    Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
    Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High recurrent rate of multicentric papillary thyroid carcinoma.
    Lin JD; Chao TC; Hsueh C; Kuo SF
    Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 73.